Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer

Documenti analoghi

• Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
  di: Doebele, Robert C., et al.
  Pubblicazione: (2012)
• Native and rearranged ALK copy number and rearranged cell count in NSCLC: Implications for ALK inhibitor therapy
  di: Camidge, D. Ross, et al.
  Pubblicazione: (2013)
• Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
  di: Camidge, D. Ross, et al.
  Pubblicazione: (2010)
• Correlations between the percentage of tumor cells showing an ALK gene rearrangement, ALK signal copy number and response to crizotinib therapy in ALK FISH positive non-small cell lung cancer
  di: Camidge, D. Ross, et al.
  Pubblicazione: (2012)
• Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
  di: Butrynski, James E., et al.
  Pubblicazione: (2010)